Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ: RIGL · Real-Time Price · USD

48.92

+1.54 (3.25%)

At close: Dec 5, 2025, 4:00 PM EST

50.64

+1.72 (3.52%)

After-hours: Dec 5, 2025, 7:45 PM EST

Rigel Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Operating Revenue	282.08	179.28	115.78	115.74	138.74	108.62	Upgrade
Other Revenue	-	-	0.1	-	-	-	Upgrade
Revenue	282.08	179.28	115.88	115.74	138.74	108.62	Upgrade
Revenue Growth (YoY)	79.13%	54.71%	0.12%	-16.57%	27.73%	83.21%	Upgrade
Cost of Revenue	47.7	42.03	31.63	62.02	66.32	61	Upgrade
Gross Profit	234.38	137.25	84.25	53.72	72.42	47.63	Upgrade
Selling, General & Admin	115.43	113.06	105.74	112.45	91.89	76.6	Upgrade
Operating Expenses	115.43	113.06	105.74	112.45	91.89	76.6	Upgrade
Operating Income	118.95	24.19	-21.49	-58.73	-19.48	-28.97	Upgrade
Interest Expense	-7.58	-7.92	-6.87	-3.71	-4.86	-1.35	Upgrade
Interest & Investment Income	2.96	2.09	2.27	0.68	0.05	0.58	Upgrade
EBT Excluding Unusual Items	114.34	18.37	-26.09	-61.75	-24.29	-29.74	Upgrade
Merger & Restructuring Charges	-	-	-	-1.32	-3.52	-	Upgrade
Other Unusual Items	-	-	1	4.5	10.5	-	Upgrade
Pretax Income	114.34	18.37	-25.09	-58.57	-17.31	-29.74	Upgrade
Income Tax Expense	1.04	0.88	-	-	0.61	-	Upgrade
Net Income	113.3	17.49	-25.09	-58.57	-17.91	-29.74	Upgrade
Net Income to Common	113.3	17.49	-25.09	-58.57	-17.91	-29.74	Upgrade
Shares Outstanding (Basic)	18	18	17	17	17	17	Upgrade
Shares Outstanding (Diluted)	18	18	17	17	17	17	Upgrade
Shares Change (YoY)	4.06%	1.64%	2.07%	-0.00%	1.03%	0.81%	Upgrade
EPS (Basic)	6.35	0.99	-1.44	-3.44	-1.05	-1.76	Upgrade
EPS (Diluted)	6.20	0.99	-1.44	-3.44	-1.05	-1.76	Upgrade
Free Cash Flow	68.14	31.44	-5.74	-74.21	5.25	-53.45	Upgrade
Free Cash Flow Per Share	3.73	1.78	-0.33	-4.35	0.31	-3.17	Upgrade
Gross Margin	83.09%	76.56%	72.70%	46.41%	52.20%	43.84%	Upgrade
Operating Margin	42.17%	13.49%	-18.55%	-50.74%	-14.04%	-26.67%	Upgrade
Profit Margin	40.17%	9.75%	-21.65%	-50.61%	-12.91%	-27.38%	Upgrade
Free Cash Flow Margin	24.16%	17.53%	-4.96%	-64.11%	3.79%	-49.20%	Upgrade
EBITDA	121.37	26.42	-20.25	-57.73	-18.31	-28.27	Upgrade
EBITDA Margin	43.03%	14.74%	-17.48%	-49.88%	-13.20%	-26.02%	Upgrade
D&A For EBITDA	2.42	2.23	1.24	1	1.16	0.71	Upgrade
EBIT	118.95	24.19	-21.49	-58.73	-19.48	-28.97	Upgrade
EBIT Margin	42.17%	13.49%	-18.55%	-50.74%	-14.04%	-26.67%	Upgrade
Effective Tax Rate	0.91%	4.80%	-	-	-	-	Upgrade
Revenue as Reported	282.08	179.28	116.88	120.24	149.24	108.62	Upgrade

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q